logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

T Cell Sciences, Inc.


USPTO Granted Patents = 24


Forward Citations = 605

Loading Chart...
Loading Chart...

39 inventors (with patents filed for the assignee):

goldMedal Stephen H Ip (18 out of 28 patents)

silverMedal Henry C Marsh (8 out of 17 patents)

bronzeMedal Robert D Sindelar (6 out of 6 patents)

4.  Barton J Bradbury (6 out of 17 patents)

5.  Savvas C Makrides (5 out of 7 patents)

6.  Patrick C Kung (5 out of 14 patents)

7.  Lloyd B Klickstein (4 out of 13 patents)

8.  Michael B Brenner (4 out of 30 patents)

9.  Michael F Concino (4 out of 27 patents)

10.  Jack L Strominger (4 out of 41 patents)

11.  Douglas T Fearon (4 out of 7 patents)

12.  Gerald R Carson (4 out of 6 patents)

13.  Winnie W Wong (4 out of 6 patents)

14.  Michael S Krangel (4 out of 7 patents)

15.  Teodoro S Kaufman (4 out of 4 patents)


24 patents:

1. 5976540 - Compositions comprising complement related proteins and carbohydrates, (1999-11-02),
2. 5858969 - Therapeutic methods employing sialylated glycoforms of soluble (1999-01-12),
3. 5856300 - Compositions comprising complement related proteins and carbohydrates, (1999-01-05),
4. 5856297 - Human C3b/C4b receptor (CR1) (1999-01-05),
5. 5840858 - Protein purification using immobilized metal affinity chromatography for (1998-11-24),
6. 5808109 - Compounds that inhibit complement and/or suppress immune activity (1998-09-15),
7. 5656659 - Compounds which inhibit complement and/or suppress immune activity (1997-08-12),
8. 5601822 - .gamma., .delta. T cell receptor and methods for detection (1997-02-11),
9. 5552300 - T cell antigen receptor V region proteins and methods of preparation (1996-09-03),
10. 5506247 - Compounds that inhibit complement and/or suppress immune activity (1996-04-09),
11. 5472939 - Method of treating complement mediated disorders (1995-12-05),
12. 5456909 - Glycoform fractions of recombinant soluble complement receptor 1 (sCR1) (1995-10-10),
13. 5436319 - Cell free T cell antigen receptor beta chain and its clinical utilities (1995-07-25),
14. 5401767 - Compounds which inhibit complement and/or suppress immune activity (1995-03-28),
15. 5366986 - Compounds which inhibit complement and/or suppress immune activity (1994-11-22),
T Cell Sciences, Inc. is a biotechnology company specializing in the development of immunotherapies for various diseases. Founded in 1983, the company focuses on harnessing the power of T cells to combat cancer, autoimmune disorders, and infectious diseases. Their innovative research and development efforts have led to groundbreaking treatments that have the potential to revolutionize healthcare. With a team of top scientists and experts in the field, T Cell Sciences is dedicated to improving patient outcomes and advancing the field of immunotherapy.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

24 Patents

#95 in Cambridge, MA

#799 in Massachusetts

#13,415 in US

#25,860 in the World

...
Cambridge, MA, United States of America

T Cell Sciences, Inc.

Forward Citations = 605

39 inventors:

goldMedal Stephen H Ip (18 out of 28 patents)

silverMedal Henry C Marsh (8 out of 17 patents)

bronzeMedal Robert D Sindelar (6 out of 6 patents)

4.  Barton J Bradbury (6 out of 17 patents)

5.  Savvas C Makrides (5 out of 7 patents)

Please report any incorrect information to support@idiyas.com
Loading…